LPCN - Lipocine GAAP EPS of -$0.13 in-line revenue of $0.5M misses by $0.91M
2023-03-10 09:31:06 ET
- Lipocine press release ( NASDAQ: LPCN ): FY GAAP EPS of -$0.13 in-line.
- Revenue of $0.5M (-96.9% Y/Y) misses by $0.91M .
- As of December 31, 2022, Lipocine had $32.5 million of unrestricted cash, cash equivalents and marketable investment securities compared to $46.6 million at December 31, 2021.
- Shares -1% .
For further details see:
Lipocine GAAP EPS of -$0.13 in-line, revenue of $0.5M misses by $0.91M